Verano Holdings (VRNO) Gross Profit (2021 - 2026)
Verano Holdings' (VRNO) quarterly Gross Profit came in at $99.0 million in Q1 2026, down 0.61% year-on-year from $99.6 million in Q1 2025, and down 6.36% on a QoQ basis from $105.7 million in Q4 2025.
Verano Holdings (VRNO) Gross Profit (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Gross Profit data on file, last reported at $99.0 million in Q1 2026.
- On a quarterly basis, Gross Profit fell 0.61% year-over-year to $99.0 million in Q1 2026; TTM through Mar 2026 was $412.9 million, a 4.1% decrease from a year earlier, with the FY2025 full-year figure at $413.5 million, down 6.86% from the prior year.
- Gross Profit for Q1 2026 stood at $99.0 million, down from $105.7 million in the prior quarter.
- Over the last five years, Gross Profit for VRNO reached as high as $133.2 million in Q3 2023 and fell as low as $95.2 million in Q3 2025.
- Historically, Gross Profit has averaged $109.1 million across 5 years, with a median of $109.1 million in 2024.
- Across the five-year window, Gross Profit jumped 41.76% in 2022 and declined 18.11% in 2024, its largest moves.
- Year by year, Gross Profit stood at $103.3 million in 2022, then increased by 13.81% to $117.6 million in 2023, then decreased by 8.57% to $107.5 million in 2024, then slipped by 1.71% to $105.7 million in 2025, then dropped by 6.36% to $99.0 million in 2026.
- Per Business Quant data, the three most recent Gross Profit figures were $99.0 million in Q1 2026, $105.7 million in Q4 2025, and $95.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.98 Mn |
| Mar 31, 2026 | 98.98 Mn |
| Dec 31, 2025 | 105.70 Mn |
| Dec 31, 2025 | 105.70 Mn |
| Sep 30, 2025 | 95.24 Mn |
| Sep 30, 2025 | 95.24 Mn |
| Jun 30, 2025 | 112.98 Mn |
| Jun 30, 2025 | 112.98 Mn |
| Mar 31, 2025 | 99.58 Mn |
| Mar 31, 2025 | 99.58 Mn |
| Dec 31, 2024 | 107.53 Mn |
| Dec 31, 2024 | 107.53 Mn |
| Sep 30, 2024 | 109.10 Mn |
| Sep 30, 2024 | 109.10 Mn |
| Jun 30, 2024 | 114.34 Mn |
| Jun 30, 2024 | 114.34 Mn |
| Mar 31, 2024 | 112.96 Mn |
| Mar 31, 2024 | 112.96 Mn |
| Dec 31, 2023 | 117.61 Mn |
| Dec 31, 2023 | 117.61 Mn |